Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.41%
#3 Cysic Cysic +25.00%
#4 Velvet Velvet +21.00%
#5 Fabric Protocol Fabric Protocol +18.27%
#6 Bedrock Bedrock +17.29%
#7 Nillion Nillion +16.73%
#8 Nockchain Nockchain +14.69%
#9 Perle Perle +12.86%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Peringkat dalam Saham #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Harga Saham
$0.00060315
Terakhir disinkronkan: 2024-09-27
Kapitalisasi Pasar
$1.65M
Perubahan (1 hari)
19.64%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Amniotics AB (publ) (AMNI)

Kategori

Healthcare
Rasio P/B untuk Amniotics AB (publ) (AMNI)
Rasio P/B per August 2026 TTM: 0.98
Menurut laporan keuangan dan harga saham terbaru dari Amniotics AB (publ), rasio P/B saat ini (TTM) adalah 0.98. Pada akhir 2022, rasio P/B perusahaan adalah 43.73.
Riwayat rasio P/B untuk Amniotics AB (publ) dari 2018 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
2026 (TTM) 0.98 -40.17%
2023 1.63 -96.28%
2022 43.73 263.99%
2021 12.01 -34.02%
2020 18.21 -69.40%
2019 59.51 -75.80%
2018 245.87 0.00%
Rasio P/B untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/B Perbedaan Rasio P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 550.32%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 540.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 254.92%
BE